The BIOFIRE TORCH System uses multiplex PCR technology to simultaneously test for a comprehensive grouping of targets in about an hour.

This alternative method to traditional stool testing is fast, sensitive, and comprehensive with a panel menu that includes bacteria, viruses, and parasites, causing infectious gastroenteritis.

The BIOFIRE^® Respiratory 2.1 (RP2.1) Panel use the syndromic approach to accurately detect and identify the pathogens most associated with respiratory infections. Fast and comprehensive results may enable better-informed diagnosis and treatment of patients.

The BIOFIRE ME Panel detects on 14 of the most common bacterial, viral, and yeast pathogens that cause central nervous system infections to help healthcare providers rapidly distinguish between bacterial and viral meningitis and optimize life-saving therapy. 

Using PCR technology, the BIOFIRE JI Panel is a syndromic test that delivers comprehensive results in one easy-to-read report.

Syndromic tests targeting a comprehensive menu of bacteria and viruses that cause pneumonia and other lower respiratory tract infections, as well as 7 genetic markers of antibiotic resistance.

The BIOFIRE BCID2 Panel tests for 43 targets associated with bloodstream infections, including Gram-negative bacteria, Gram-positive bacteria, yeast, and 10 antimicrobial resistance genes – all with one test and with results available in about an hour from positive blood culture.

The BIOFIRE 2.0 EZ Configuration facilitates rapid near-patient molecular diagnostic testing with results in about 45 minutes.

The BIOFIRE RP2.1-EZ Panel (EUA)* uses a syndromic approach to quickly identify SARS-CoV-2, along with 18 additional viral and bacterial pathogens with results in about 45 minutes.

Product not available outside of the U.S.